GYRE THERAPEUTICS, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Gyre Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Gyre Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $139K, a 9.45% increase year-over-year.
  • Gyre Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $573K, a 10.8% increase from 2022.
  • Gyre Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $517K, a 72% decline from 2021.
  • Gyre Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $1.85M, a 207% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $573K +$56K +10.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $517K -$1.33M -72% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $1.85M +$1.25M +207% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $602K +$40K +7.12% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $562K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.